# Tagraxofusp (Genetical Recombination) I.V. Infusion 1000μg (エルゾンリス点滴静注１０００μｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291482A1023). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291482A1023
- **Product name (Japanese):** エルゾンリス点滴静注１０００μｇ
- **English title:** Tagraxofusp (Genetical Recombination) I.V. Infusion 1000μg
- **Active ingredient:** タグラキソフスプ（遺伝子組換え）
- **Active ingredient (INN):** Tagraxofusp (Genetical Recombination)
- **Strength / unit:** １，０００μｇ１ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Nippon Shinyaku (日本新薬)
- **NHI price (reference only):** JPY 3607878 per １，０００μｇ１ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291482A1023
- **JSON:** https://www.nifujipharma.com/api/drugs/4291482A1023

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Tagraxofusp%20(Genetical%20Recombination)%20I.V.%20Infusion%201000%CE%BCg%20(%E3%82%A8%E3%83%AB%E3%82%BE%E3%83%B3%E3%83%AA%E3%82%B9%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BC%90%CE%BC%EF%BD%87)%20%2F%20YJ%204291482A1023#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.